In Thailand, the dental and human markets are growing quickly, thanks to the capillary promotional work of our partners IMS and Dental Siam, together with their constant participation in important initiatives and conventions structured to render ASAlaser therapy solutions more visible.
December was full of appointments, with Dental Siam busily taking part in the 100th edition of the TDA Congress (The Dental Association of Thailand), which was held in Bangkok from 15th to 17th December: with the 100 exhibitors who welcomed more than 2000 visitors, there was no better occasion for presenting MLS® Laser Therapy and receiving positive feedback. Important results were also obtained by IMS, which participated in the annual meeting of “The Royal College of Physiatrists of Thailand”, organized by the Thai Association of Rehabilitation Medicine from 10 to 12 December in Pattaya, Gulf of Thailand. For the occasion, our local partner’s team showcased Mphi 5 (MLS® Laser Therapy) and Hiro 3.0 (Hilterapia®), both of which attracted a large number of visitors to the stand.
“The interest in our therapy solutions for humans over these last few months was high,” said Mrs. Panom, the Vice President of IMS. “The proof comes from the number of doctors and specialists who now use MLS® and Hilterapia® in their daily work.”
The activities in Thailand will end positively with Dr. Chakarg Pongurgsor’s speech. Dr. Pongurgsor, who has been using M6 and Hiro 3.0 as laser therapy innovations to treat problems tied to medicine in sport, will give his speech at the seminary on research and clinical practice that will take place from 22nd to 24th December in Bangkok.
L'accesso alla visualizzazione dei prodotti e al materiale informativo è riservato agli operatori del settore in ottemperanza alla legislazione vigente. ASA richiede di qualificarsi come operatore del settore per procedere con la navigazione.
Decreto Legislativo 24 febbraio 1997, n°46 Articolo 21
1. E' vietata la pubblicità verso il pubblico dei dispositivi che, secondo disposizioni adottate con decreto del Ministro della Sanità, possono essere venduti soltanto su prescrizione medica o essere impiegati eventualmente con l'assistenza di un medico o di altro professionista sanitario.
2. La pubblicità presso il pubblico dei dispositivi diversi da quelli di cui al comma 1 è soggetta ad autorizzazione del Ministero della Sanità. Sulle domande di autorizzazione esprime parere la Commissione di esperti prevista dall'articolo 6, comma 3, del decreto legislativo
30 dicembre 1992, n. 541, che a tal fine è integrata da un rappresentante del Dipartimento del Ministero della Sanità competente in materia di dispositivi medici e da uno del Ministero dell'Industria, del commercio e dell'artigianato.
Some of the contents of this website cannot be disclosed in the USA and its territories and possesions, for regulatory reasons. If you are a US resident, please click on the button here below and access ASA's distributor website for North America.